{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:56:23Z","timestamp":1787496983268,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>This report presents a case of IgG4-related sclerosing cholangitis (IgG4-SC) in a patient who ultimately died from a complex postoperative infection. The patient was a 59-year-old male who underwent resection of a hilar lesion and Roux-en-Y hepaticojejunostomy (RYHJ) for obstructive jaundice 7\u202fyears ago, with postoperative pathology confirming IgG4-SC. However, from 4\u202fmonths after surgery, the patient experienced recurrent fever episodes that persisted for 7\u202fyears. The clinical presentation was consistent with sump syndrome. Both recurrent infections and IgG4-SC disease activity can elevate IgG4 levels, complicating clinical assessment. Despite aggressive antibiotic therapy combined with immunosuppressive treatment, the infections recurred. The patient eventually succumbed to sepsis in August 2025, triggered by recurrent cholangitis. This case underscores the importance of differentiating IgG4-SC from hilar cholangiocarcinoma (HC) to avoid unnecessary surgery. Moreover, it highlights that in post-hepaticojejunostomy patients, distinguishing whether elevated IgG4 levels signify disease activity or are secondary to infection is essential for guiding therapy.<\/jats:p>","DOI":"10.3389\/fmed.2025.1730125","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:17:00Z","timestamp":1768205820000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Sump syndrome following hepaticojejunostomy: a case report of IgG4-related sclerosing cholangitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Liqin","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HanYing","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3349\/ymj.2012.53.1.15","article-title":"IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease","volume":"53","author":"Divatia","year":"2012","journal-title":"Yonsei Med J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jhbp.793","article-title":"Epidemiological features of immunoglobulin G4-related sclerosing cholangitis in Japan","volume":"27","author":"Tanaka","year":"2020","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.dld.2021.02.009","article-title":"Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: comparison of cases with and without autoimmune pancreatitis in a large cohort","volume":"53","author":"Naitoh","year":"2021","journal-title":"Dig Liver Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/MCG.0000000000001984","article-title":"A review of IgG4-related sclerosing cholangitis (IgG4-SC)","volume":"58","author":"Khoury","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14735\/amko2019143","article-title":"IgG4 sclerosing cholangitis\u2014an inflammation imitating tumour of the pancreas and biliary tract","volume":"32","author":"Pe\u0148\u00e1zov\u00e1","year":"2019","journal-title":"Klin Onkol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2298\/sarh1506337i","article-title":"A case of autoimmune cholangitis misdiagnosed for cholangiocarcinoma: how to avoid unnecessary surgical intervention?","volume":"143","author":"Ignjatovi\u0107","year":"2015","journal-title":"Srp Arh Celok Lek"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1385214","DOI":"10.3389\/fonc.2024.1385214","article-title":"Case report: isolated immunoglobulin G4-related sclerosing cholangitis misdiagnosed as hilar cholangiocarcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1111\/liv.15036","article-title":"Management, outcomes and survival of an Australian IgG4-SC cohort: the MOSAIC study","volume":"41","author":"Kemp","year":"2021","journal-title":"Liver Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cgh.2016.12.038","article-title":"Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis","volume":"15","author":"Tanaka","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1959832","DOI":"10.1155\/2021\/1959832","article-title":"IgG4-related sclerosing cholangitis: rarely diagnosed, but not a rare disease","volume":"2021","author":"Drazilova","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jhbp.596","article-title":"Clinical practice guidelines for IgG4-related sclerosing cholangitis","volume":"26","author":"Kamisawa","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"goaf032","DOI":"10.1093\/gastro\/goaf032","article-title":"Management of IgG4-related cholangitis: diagnosis, therapy, and long-term surveillance","volume":"13","author":"Herta","year":"2025","journal-title":"Gastroenterol Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1245\/s10434-021-09871-6","article-title":"The landmark series: hilar cholangiocarcinoma","volume":"28","author":"Soares","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijsu.2015.05.004","article-title":"Long-term follow-up of 120 patients after hepaticojejunostomy for treatment of post-cholecystectomy bile duct injuries: a retrospective cohort study","volume":"18","author":"AbdelRafee","year":"2015","journal-title":"Int J Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0039-6060(96)80139-5","article-title":"Sump syndrome complicating Roux-en-Y hepaticojejunostomy: case report and review of the literature","volume":"119","author":"Morrissey","year":"1996","journal-title":"Surgery"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1159\/000477335","article-title":"Sump syndrome: a rare long-term complication of choledochoduodenostomy","volume":"11","author":"Abraham","year":"2017","journal-title":"Case Rep Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e9378","DOI":"10.1002\/ccr3.9378","article-title":"Sump syndrome: diagnosis dilemmas and therapeutic approaches-a case series","volume":"12","author":"Abbarh","year":"2024","journal-title":"Clin Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s1499-3872(11)60043-x","article-title":"Clinical features and treatment of sump syndrome following hepaticojejunostomy","volume":"10","author":"Marangoni","year":"2011","journal-title":"Hepatobiliary Pancreatic Dis Int"},{"key":"ref20","first-page":"1255","article-title":"Could recurrent cholangitis after Roux-en-Y hepaticojejunostomy be explained by motor intestinal anomalies? A manometric study","volume":"86","author":"Ducrotte","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/20009666.2021.1949794","article-title":"Sump syndrome of the remnant common bile duct following a living donor liver transplant","volume":"11","author":"Robbins","year":"2021","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10067-022-06413-7","article-title":"Roles of IgG4 and IgG4\/IgG ratio to IgG4-related disease in patients with elevated serum IgG4 level","volume":"42","author":"Wang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5536057","DOI":"10.1155\/2024\/5536057","article-title":"A rare cause of pain in a patient following Roux-en-Y choledochojejunostomy","volume":"2024","author":"Sather","year":"2024","journal-title":"Case Rep Surg"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.12659\/AJCR.890436","article-title":"Successful treatment of recurrent cholangitis by constructing a hepaticojejunostomy with long Roux-en-Y limb in a long-term surviving patient after a whipple procedure for pancreatic adenocarcinoma","volume":"15","author":"Tsalis","year":"2014","journal-title":"Am J Case Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.9738\/INTSURG-D-13-00243.1","article-title":"Recurrent cholangitis by biliary stasis due to non-obstructive afferent loop syndrome after pylorus-preserving pancreatoduodenectomy: report of a case","volume":"99","author":"Sanada","year":"2014","journal-title":"Int Surg"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"E174","DOI":"10.1055\/a-1216-1220","article-title":"Duckbill-type antireflux self-expandable metal stent placement for post-choledochojejunostomy reflux cholangitis","volume":"53","author":"Koga","year":"2021","journal-title":"Endoscopy"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1055\/a-1956-1055","article-title":"A novel triple stenting in the treatment of post-choledochojejunostomy reflux cholangitis","volume":"55","author":"Maehara","year":"2022","journal-title":"Endoscopy"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1730125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:17:04Z","timestamp":1768205824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1730125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":28,"alternative-id":["10.3389\/fmed.2025.1730125"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1730125","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1730125"}}